Literature DB >> 11090399

Detection of hepatic lesions in candidates for surgery: comparison of ferumoxides-enhanced MR imaging and dual-phase helical CT.

D A Bluemke1, E K Paulson, M A Choti, S DeSena, P A Clavien.   

Abstract

OBJECTIVE: The purpose of this study was to compare the use of phased array MR imaging of the liver at 1.5 T with and without ferumoxides with dual-phase helical CT for the detection of hepatic lesions in candidates for hepatic surgery. SUBJECTS AND METHODS: Patients with known or suspected hepatic lesions who were eligible for surgery underwent dual-phase helical CT at 20 and 70 sec after the start of contrast material injection and phased array MR imaging using fast spin-echo T2-weighted imaging and gradient-echo T1-weighted imaging before and after ferumoxides infusion of 0.56 mg of iron per kilogram of body weight. Three observers who were unaware of the surgical findings separately reviewed the CT scans and unenhanced and enhanced MR images of 24 patients who completed the protocol. The observers' findings were compared with results obtained at surgery using intraoperative sonography and having histopathologic confirmation. Statistical analysis was performed using a segment-by-segment analysis.
RESULTS: Eighty-two lesions were found at surgery. The sensitivity of CT, unenhanced MR imaging, and enhanced MR imaging for blinded observers was 60.4%, 62.0%, and 68.2%, respectively. The specificity was 89.2%, 81.9%, and 81.6%, respectively. Five lesions in three patients were not detected preoperatively using any of the techniques. MR imaging found additional lesions not detected on CT in four patients; CT detected one additional lesion not seen on MR imaging.
CONCLUSION: Ferumoxides-enhanced MR imaging of the liver shows a trend toward increased sensitivity compared with dual-phase helical CT. Specificity of helical CT was superior to that of enhanced MR imaging for most observers.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11090399     DOI: 10.2214/ajr.175.6.1751653

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  10 in total

Review 1.  [Modern imaging for liver metastases from colorectal tumors].

Authors:  J Gaa; H Wieder; M Schwaiger; E J Rummeny
Journal:  Chirurg       Date:  2005-06       Impact factor: 0.955

2.  Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast-enhanced computed tomography in metastatic disease of the liver: diagnostic performance and confidence.

Authors:  Emilio Quaia; Mirko D'Onofrio; Alessandro Palumbo; Stefania Rossi; Stefano Bruni; Maria Cova
Journal:  Eur Radiol       Date:  2006-03-22       Impact factor: 5.315

3.  Diagnostic performance of MDCT, PET/CT and gadoxetic acid (Primovist(®))-enhanced MRI in patients with colorectal liver metastases being considered for hepatic resection: initial experience in a single centre.

Authors:  V O Chan; J P Das; J F Gerstenmaier; J Geoghegan; R G Gibney; C D Collins; S J Skehan; D E Malone
Journal:  Ir J Med Sci       Date:  2012-03-17       Impact factor: 1.568

Review 4.  Do the benefits outweigh the side effects of colorectal cancer surveillance? A systematic review.

Authors:  Knut Magne Augestad; Johnie Rose; Benjamin Crawshaw; Gregory Cooper; Conor Delaney
Journal:  World J Gastrointest Oncol       Date:  2014-05-15

5.  Characterization of focal liver lesions with superparamagnetic iron oxide-enhanced MR imaging: value of distributional phase T1-weighted imaging.

Authors:  Jeong Min Lee; Chong Soo Kim; Ji Hyun Youk; Mi Suk Lee
Journal:  Korean J Radiol       Date:  2003 Jan-Mar       Impact factor: 3.500

6.  Characterization of focal hepatic lesions with SPIO-enhanced MRI.

Authors:  Wei-Wei Zheng; Kang-Rong Zhou; Zu-Wang Chen; Ji-Zhang Shen; Cai-Zhong Chen; Shu-Jie Zhang
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

7.  Detection of hepatic VX2 tumors in rabbits: comparison of conventional US and phase-inversion harmonic US during the liver-specific late phase of contrast enhancement.

Authors:  Jeong Min Lee; Ji Hyun Youk; Young Hwan Lee; Young Kon Kim; Chong Soo Kim; Chun Ai Li
Journal:  Korean J Radiol       Date:  2003 Apr-Jun       Impact factor: 3.500

8.  Small (<or=3 cm) hepatocellular carcinoma in cirrhosis: the role of double contrast agents in MR imaging vs. multidetector-row CT.

Authors:  R Golfieri; E Marini; A Bazzocchi; F Fusco; F Trevisani; C Sama; G Mazzella; S Cavuto; F Piscaglia; L Bolondi
Journal:  Radiol Med       Date:  2009-08-20       Impact factor: 3.469

9.  Detection of small hypervascular hepatocellular carcinomas in cirrhotic patients: comparison of superparamagnetic iron oxide-enhanced MR imaging with dual-phase spiral CT.

Authors:  Jeong-Min Lee; In-Hwan Kim; Hyo-Sung Kwak; Ji-Hyun Youk; Young-Min Han; Chong-Soo Kim
Journal:  Korean J Radiol       Date:  2003 Jan-Mar       Impact factor: 3.500

10.  Liver cancer imaging: role of CT, MRI, US and PET.

Authors:  Maria Raquel Oliva; Sanjay Saini
Journal:  Cancer Imaging       Date:  2004-04-02       Impact factor: 3.909

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.